1. Home
  2. IKT vs RDNW Comparison

IKT vs RDNW Comparison

Compare IKT & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.82

Market Cap

220.5M

Sector

Health Care

ML Signal

HOLD

RDNW

RideNow Group Inc.

HOLD

Current Price

$7.40

Market Cap

221.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IKT
RDNW
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
220.5M
221.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IKT
RDNW
Price
$1.82
$7.40
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$5.00
$6.50
AVG Volume (30 Days)
583.1K
86.5K
Earning Date
03-26-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
57.76
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.01
Revenue Next Year
N/A
$6.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$2.98
52 Week High
$2.26
$8.55

Technical Indicators

Market Signals
Indicator
IKT
RDNW
Relative Strength Index (RSI) 61.33 48.09
Support Level $1.63 $7.16
Resistance Level $1.91 $8.36
Average True Range (ATR) 0.08 0.58
MACD 0.02 -0.06
Stochastic Oscillator 100.00 31.08

Price Performance

Historical Comparison
IKT
RDNW

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.

About RDNW RideNow Group Inc.

RideNow Group Inc is a USA-based online retailer that allows consumers and dealers both to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience.

Share on Social Networks: